Ownership history in EARNED WEALTH ADVISORS, LLC · 15 quarters on record
This page tracks every 13F SEC filing in which EARNED WEALTH ADVISORS, LLC reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 25,975 | — | 0% | 0.00% | $47K | $1.80 |
| 2025 Q3 | REDUCED | 25,975 | -1 | -0.0% | 0.01% | $58K | $2.22 |
| 2025 Q2 | UNCHANGED | 25,976 | — | 0% | 0.01% | $38K | $1.48 |
| 2025 Q1 | UNCHANGED | 25,976 | — | 0% | 0.01% | $66K | $2.56 |
| 2024 Q4 | UNCHANGED | 25,976 | — | 0% | 0.02% | $49K | $1.88 |
| 2024 Q3 | REDUCED | 25,976 | -817 | -3.0% | 0.01% | $26K | $1.02 |
| 2024 Q2 | ADDED | 26,793 | +535 | +2.0% | 0.01% | $31K | $1.17 |
| 2024 Q1 | ADDED | 26,258 | +283 | +1.1% | 0.01% | $33K | $1.26 |
| 2023 Q4 | ADDED | 25,975 | +1 | +0.0% | 0.02% | $46K | $1.78 |
| 2023 Q3 | UNCHANGED | 25,974 | — | 0% | 0.02% | $43K | $1.66 |
As of 2025 Q4 — sorted by position size